Citadel Advisors - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$47,867,570
+486.9%
1,246,876
+190.0%
0.01%
+900.0%
Q2 2023$8,156,132
-59.8%
429,949
-67.1%
0.00%
-75.0%
Q1 2023$20,286,708
-2.1%
1,307,976
+12.0%
0.00%
-20.0%
Q4 2022$20,723,516
+1735.6%
1,167,522
+477.0%
0.01%
Q3 2022$1,129,000
-14.6%
202,333
-40.3%
0.00%
Q2 2022$1,322,000
-48.6%
338,905
-27.4%
0.00%
Q1 2022$2,570,000
-57.1%
466,591
-33.6%
0.00%
-100.0%
Q4 2021$5,991,000
-39.3%
703,161
-38.1%
0.00%0.0%
Q3 2021$9,874,000
-24.9%
1,136,243
-8.6%
0.00%
-50.0%
Q2 2021$13,146,000
+5.0%
1,243,712
+59.4%
0.00%
-33.3%
Q1 2021$12,516,000
-64.8%
780,341
+1.5%
0.00%
-66.7%
Q4 2020$35,521,000
+44.0%
769,034
+9.7%
0.01%
+28.6%
Q3 2020$24,671,000
+374.3%
701,075
+228.1%
0.01%
+250.0%
Q2 2020$5,202,000
+1784.8%
213,652
+1103.3%
0.00%
Q1 2020$276,00017,7560.00%
Other shareholders
IMMUNOVANT INC shareholders Q2 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders